Effect of Cell Culture Medium on the Proliferation and Stemness of CD24-/CD44+ Human Breast Cancer Stem Cells

被引:3
|
作者
Nadia, Yalista Fatia [1 ]
Syahrani, Resda Akhra [2 ]
Arumsari, Sekar [2 ]
Sadikin, Mohamad [3 ]
Wanandi, Septelia Inawati [2 ,3 ]
机构
[1] Univ Indonesia, Fac Med, Masters Programme Biomed Sci, Jl Salemba Raya, Jakarta 10430, Indonesia
[2] Univ Indonesia, Fac Med, Molectdar Biol & Protc Core Facil, Indonesian Med Educ & Res Inst IMERI, Jl Salemba Raya, Jakarta 10430, Indonesia
[3] Univ Indonesia, Fac Med, Dept Biochem & Mol Biol, Jl Salemba Raya, Jakarta 10430, Indonesia
来源
INDONESIAN BIOMEDICAL JOURNAL | 2021年 / 13卷 / 04期
关键词
breast cancer; cancer stem cell; OCT4; stemness; proliferation; TARGET; HEPES;
D O I
10.18585/inabj.v13i4.1674
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BACKGROUND: Cancer stem cells (CSCs) is defined as tumor initiating cells within tumor that maintain stemness properties and tumorigenicity. Extracellular pH of CSCs in in vitro condition is important for supporting cell proliferation which may also regulate the expression of stemness markers such as OCT4. This work aimed to examine the effect of cell culture media on the proliferation and stemness of human breast cancer stem cells (BCSCs). METHODS: Human CD24(-)/CD44(+) BCSCs were grown in Dulbecco's Modified Eagle Medium/F-12 (DMEM/F-12) with 15mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), without HEPES and adjusted to pH 7.4, or without HEPES but pH was not adjusted. BCSCs were grown under standard conditions for various days. Viable cell number was measured using trypan blue exclusion, whereas proliferation rate using MTS assay. OCT4 mRNA and protein were analyzed using quantitative real time PCR (qRT-PCR) and Western Blot assay, respectively. In vitro tumorigenic activity was determined using mammosphere formation unit (MFU) assay. RESULTS: Our results showed a higher viable cell number and proliferation of BCSCs in DMEM/F-12 HEPES (-) compared to HEPES (+) medium until 4 day incubation. OCT4 mRNA and protein level, as well as MFU of BCSCs were significantly higher in HEPES (-) compared to HEPES (+) medium on day 2. CONCLUSION: DMEM/F-12 medium without HEPES facilitates CD24(-)/CD44(+) BCSCs to have higher proliferation and stemness on day 2 incubation compared to those with HEPES.
引用
收藏
页码:355 / 363
页数:9
相关论文
共 50 条
  • [1] Expression of CD44+/CD24- Cells in Breast Cancer
    Lu, X. Q.
    Suo, Z. H.
    Ma, C. L.
    Xu, K. J.
    Liu, Y. S.
    Li, H. X.
    LABORATORY INVESTIGATION, 2009, 89 : 55A - 55A
  • [2] Expression of CD44+/CD24- Cells in Breast Cancer
    Lu, X. Q.
    Suo, Z. H.
    Ma, C. L.
    Xu, K. J.
    Liu, Y. S.
    Li, H. X.
    MODERN PATHOLOGY, 2009, 22 : 55A - 55A
  • [3] CD44+/CD24- cancer stem cell in breast tissue distribution and prevalence
    Swiatek, J.
    Kaerner, A.
    Heil, J.
    Aulmann, S.
    Sinn, H.
    Sohn, C.
    Gebauer, G.
    ONKOLOGIE, 2008, 31 : 51 - 52
  • [4] Reduction of CD44+/CD24- breast cancer cells by conventional cytotoxic chemotherapy
    Aulmann, Sebastian
    Waldburger, Nina
    Penzel, Roland
    Andrulis, Mindaugas
    Schirmacher, Peter
    Sinn, Hans Peter
    HUMAN PATHOLOGY, 2010, 41 (04) : 574 - 581
  • [5] Ribosome biogenesis mediates antitumor activity of flavopiridol in CD44+/CD24- breast cancer stem cells
    Erol, Ayse
    Acikgoz, Eda
    Guven, Ummu
    Duzagac, Fahriye
    Turkkani, Ayten
    Colcimen, Nese
    Oktem, Gulperi
    ONCOLOGY LETTERS, 2017, 14 (06) : 6441 - 6448
  • [6] The impact of rotenone-modulated oxidative stress on the survival of human breast cancer stem cells (CD24-/CD44+)
    Wanandi, S. I.
    Syahrani, R. A.
    Jusman, S. W. A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] The response of CD24-/low/CD44+ breast cancer-initiating cells to radiation
    Phillips, Tiffany M.
    McBride, William H.
    Pajonk, Frank
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (24): : 1777 - 1785
  • [8] Impact of extracellular alkalinization on the survival of human CD24-//CD44+ breast cancer stem cells associated with cellular metabolic shifts
    Wanandi, S. I.
    Yustisia, I.
    Neolaka, G. M. G.
    Jusman, S. W. A.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2017, 50 (08)
  • [9] Runx2 is required for activity of CD44+/CD24-/low breast cancer stem cell in breast cancer development
    Zhang, Ping
    Liu, Lei
    Zhang, Lu
    He, Xiaogan
    Xu, Xiaojun
    Lu, Yaojuan
    Li, Feifei
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (05): : 2305 - 2318
  • [10] Brca1 breast tumors contain distinct CD44+/CD24- and CD133+cells with cancer stem cell characteristics
    Mollie H Wright
    Anna Maria Calcagno
    Crystal D Salcido
    Marisa D Carlson
    Suresh V Ambudkar
    Lyuba Varticovski
    Breast Cancer Research, 10